{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:55:55Z","timestamp":1784292955225,"version":"3.55.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T00:00:00Z","timestamp":1359936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055536","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T21:55:58Z","timestamp":1360014958000},"page":"e55536","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Balraj","family":"Premanand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mookkan","family":"Prabakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja K.","family":"Kiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Kwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"PC McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coviro.2012.02.009","article-title":"Recent advances in the molecular epidemiology and control of human enterovirus 71 infection","volume":"2","author":"PC McMinn","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1471-2334-11-270","article-title":"The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore","volume":"11","author":"LW Ang","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref4","first-page":"625","article-title":"The Cell Attachment Site on Foot-and-Mouth Disease Virus Includes the Amino Acid Sequence RGD (Arginine-Glycine-Aspartic Acid). J. Gen","volume":"70","author":"G Fox","year":"1989","journal-title":"Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1128\/JVI.62.6.2033-2040.1988","article-title":"Analysis of neutralizing epitopes on foot-and-mouth disease virus","volume":"62","author":"E Pfaff","year":"1988","journal-title":"J. Virol"},{"key":"ref6","unstructured":"Rueckert RR (1990) Picornaviruses and their replication. In: Fields, B.N., Knipe, D.M. (Eds.). Virology Lippincott-Raven, New York 507."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.antiviral.2012.05.017","article-title":"Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1","volume":"95(3)","author":"B Premanand","year":"2012","journal-title":"Antiviral Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2012.06.014","article-title":"Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice","volume":"168(1\u20132)","author":"AB Kolpe","year":"2012","journal-title":"Virus Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"DG Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2009.09.103","article-title":"Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides","volume":"390","author":"X Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","first-page":"1069","article-title":"High-titred neutralizing antibodies to human enterovirus preferentially bind to the N-terminal portion of the capsid proteinVP1. Arch","volume":"152","author":"CS Tan","year":"2007","journal-title":"Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"CN Wu","year":"2001","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2010.08.080","article-title":"Combined peptides of human enterovirus 71 protect against virus infection in mice","volume":"28","author":"JN Liu","year":"2010","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"WS Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"ref15","first-page":"430","article-title":"Vaccination strategies for mucosal immune responses. Clin. Microbiol","volume":"14","author":"PL Ogra","year":"2001","journal-title":"Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.micinf.2006.01.021","article-title":"Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71","volume":"8","author":"CH Chiu","year":"2006","journal-title":"Microbes Infect"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijmm.2007.07.001","article-title":"Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis","volume":"298","author":"H Lotter","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0264-410X(96)00236-8","article-title":"Protection in a gerbil model of amebiasis by oral immunization with Salmonella ex-pressing the galactose\/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica","volume":"15","author":"BJ Mann","year":"1997","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s004360000323","article-title":"Protection of hamsters from amebic liver abscess formation by immunization with the 150- and 170-kDa surface antigens of Entamoeba histolytica","volume":"87","author":"XJ Cheng","year":"2001","journal-title":"Parasitol Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1128\/IAI.72.12.7318-7321.2004","article-title":"Oral vac-cina-tion with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver ab-scess","volume":"72","author":"H Lotter","year":"2004","journal-title":"Infect Immun"},{"key":"ref21","first-page":"2657","article-title":"Efficient gene transfer into various mammalian cells, including non-hepatic cells, by bac-ulovirus vectors. J Gen Virol","volume":"78","author":"I Shoji","year":"1997"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/JVI.02175-09","article-title":"Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection","volume":"84","author":"M Prabakaran","year":"2010","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0168-3659(96)01352-1","article-title":"Structural requirements for intestinal absorption of peptide drugs","volume":"41","author":"GM Pauletti","year":"1996","journal-title":"J Con Rel"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/clin.1995.1019","article-title":"Development of oral vaccines to stimulate mucosal and systemic immunity:barriers and novel strategies","volume":"74","author":"WSW Shalaby","year":"1995","journal-title":"Clin Immunol Immunopath"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.vaccine.2003.11.067","article-title":"Optimization of a lipid based oral delivery system containing A\/Panama influenza hemagglutinin","volume":"22","author":"JFS Manna","year":"2004","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0264-410X(00)00348-0","article-title":"Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant cholera toxin B subunit as an adjuvant","volume":"19","author":"M Isaka","year":"2001","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2004.03.014","article-title":"Cholera toxin B subunit conjugate bile salt stabilized vesicles (bilosomes) for oral immunization","volume":"278","author":"P Singh","year":"2004","journal-title":"Int J Pharm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymeth.2005.11.002","article-title":"Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity","volume":"38","author":"JFS Mann","year":"2006","journal-title":"Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0003-2697(78)90172-0","article-title":"Rapid separation of low molecular weight solutes from liopsomes without dilution","volume":"90","author":"DW Fry","year":"1978","journal-title":"Anal Biochem"},{"key":"ref30","first-page":"107","article-title":"Improvements in methods for calculating virus titer estimating TCID50 and plaque assays. J. Virol","volume":"96","author":"DD LaBarre","year":"2001","journal-title":"Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biologicals.2004.09.001","article-title":"Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine","volume":"32","author":"D Aarthi","year":"2004","journal-title":"Biologicals"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0264-410X(00)00259-0","article-title":"Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles","volume":"19","author":"P Rueda","year":"2000","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e21757","DOI":"10.1371\/journal.pone.0021757","article-title":"Display of VP1 on the surface of Baculovirus and Its Immunogenicity against Heterologous Human enterovirus 71 Strains in Mice","volume":"6","author":"T Meng","year":"2011","journal-title":"PLoS One"},{"key":"ref34","unstructured":"O\u2019Reilly DR, Miller LK, Luckow VA (1992) Baculovirus expression vectors: a laboratory manual, p.60\u201361. W. H. Freeman and Company, New York, NY."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunization with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"M Conacher","year":"2001","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0264-410X(95)00065-9","article-title":"Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay","volume":"13","author":"JM Brewer","year":"1995","journal-title":"Vaccine"},{"key":"ref37","first-page":"e26428","article-title":"Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon","volume":"6(11)","author":"MS Syed","year":"2011","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1292\/jvms.60.1047","article-title":"Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes","volume":"60","author":"S Watarai","year":"1998","journal-title":"J Vet Med Sci"},{"key":"ref39","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","article-title":"Delivery systems and adjuvants for oral vaccines","volume":"3","author":"Lavelle Ed C","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-7799(01)01911-4","article-title":"Recombinant baculoviruses as mammalian cell gene-delivery vectors","volume":"20","author":"TA Kost","year":"2002","journal-title":"Trends Biotechnol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1128\/JVI.77.18.9799-9808.2003","article-title":"In vitro and in vivo gene delivery by recombinant baculoviruses","volume":"77","author":"CK Tani,H, Limn","year":"2003","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jgm.1311","article-title":"Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirusand adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye","volume":"11","author":"K Kinnunen","year":"2009","journal-title":"J Gene Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/167.1.84","article-title":"Oral immunization with influenza virus in biodegradable microspheres","volume":"167","author":"Z Moldoveanu","year":"1993","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0264-410X(97)00261-2","article-title":"Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres","volume":"16","author":"K Allaoui-Attarki","year":"1998","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/JVI.72.7.5757-5761.1998","article-title":"Protective immunity by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles","volume":"72","author":"SC Chen","year":"1998","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1099\/00222615-42-1-53","article-title":"Comparative antibody responses and protection in mice immunized by oral or parenteral routes with influenza virus subunit antigens in aqeous form or incorporated into ISCOMs","volume":"42","author":"HO Ghazi","year":"1995","journal-title":"J Med Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/eji.1830251019","article-title":"Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMs","volume":"25","author":"KJ Maloy","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"JF Mann","year":"2009","journal-title":"Vaccine"},{"key":"ref50","first-page":"107","article-title":"Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass culture of mammalian cells.Virology","volume":"125","author":"ST Tjia","year":"1983"},{"key":"ref51","first-page":"193","article-title":"Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium circumsporozoite protein Mol Ther","volume":"15","author":"R Strauss","year":"2007"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0141-0229(03)00143-1","article-title":"Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography","volume":"33","author":"YC Hu","year":"2003","journal-title":"Enzyme Microb Technol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T19:53:14Z","timestamp":1595361194000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055536"}},"subtitle":[],"editor":[{"given":"Robert Shin","family":"Fujinami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,4]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055536","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,4]]}}}